In a major turnaround Roche’s Kadcyla will now become routinely available on the NHS to some patients with breast cancer after a confidential deal was reached between the drug giant and NHS England.
News
Cytox raises £2.6m to help launch Alzheimer’s test
UK precision medicine group Cytox has raised £2.6 million to fund the commercial launch and international roll out of its comprehensive testing service for Alzheimer’s disease.
NHS unveils plans to better integrate care
The Head of the NHS in England has pledged to give local leaders and communities more control over how they improve health and social care to help seal up current fractures in the system that leave too many patients “passed from pillar to post”.
Further rollout for diabetes prevention programme
NHS England has announced the launch of the second wave of the Diabetes Prevention Programme, with 13 new areas now ready to offer the scheme to patients identified at risk of developing the condition.
Gov’t names two new health ministers
The government has now named the two new junior health ministers who are to replace David Mowat and Nicola Blackwood after they lost their seats in the general election.
Final NICE nod for Takeda’s Adcetris in Hodgkin’s lymphoma
Certain patients with Hodgkin’s Lymphoma living in England and Wales can now expect routine access to Takeda’s Adcetris on the NHS after NICE deemed the drug a cost-effective use of resources in some scenarios.
Rebranded UK charity to stream £500m into medical research
LifeArc, the UK medical research charity formerly known as MRC Technology, is investing £500 million over the next five years to underpin its aims of advancing innovations in antimicrobials, neuroscience, personalised oncology and respiratory medicine.
Brexit Alliance forms to protect UK patients, healthcare
NHS, medical research, industry, patients and public health organisations have come together to form a new alliance that aims to protect the UK’s interests in these areas as it negotiates to separate itself from the European Union.
QuintilesIMS partners with NHS Cancer Vanguard
Partnership will focus on Real World Data
Have you got what it takes to get a product to market?
Reflecting the multi-disciplinary nature of our industry, this year’s Marketer of the Year competition has introduced a new category which recognises market access excellence – an important part of the marketing journey: National Market Access Lead of the Year.
NICE rejects Pfizer’s ALL drug Besponsa
The National Institute for Health and Care Excellence has today published draft guidance not recommending Pfizer’s Besponsa to treat some patients with leukaemia on the NHS in England and Wales.
Multiple myeloma patients to get NHS access to Amgen’s Kyprolis
The National Institute for Health and Care Excellence is backing routine NHS use of Amgen’s Kyprolis as an option for treating patients with multiple myeloma at first relapse.
Value of CCG pound shrinking, commissioners warn
Rising inflation and an expanding population is shrinking the value of funds being streamed into clinical commissioning groups, warns NHS Clinical Commissioners.
Trial finds higher aspirin bleed risk for elderly
The use of daily aspirin as a blood thinner in people aged over 75 years is linked with a much higher risk of major and potentially fatal stomach bleeds than previously thought.
Marketer of the Year 2017: Enter now
The PharmaTimes Marketer of the Year competition is ‘open’ for entries and nominations.
